Published in Mol Cell Biol on October 01, 1988
Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet (1982) 54.79
Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc Natl Acad Sci U S A (1980) 22.30
DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. Proc Natl Acad Sci U S A (1979) 21.22
Biological applications of ionophores. Annu Rev Biochem (1976) 9.81
Polyoma virus transforming protein associates with the product of the c-src cellular gene. Nature (1983) 7.20
Transformation of rat cells by an altered polyoma virus genome expressing only the middle-T protein. Nature (1981) 6.70
Avian sarcoma virus-transforming protein, pp60src shows protein kinase activity specific for tyrosine. Nature (1980) 6.69
A short sequence in the p60src N terminus is required for p60src myristylation and membrane association and for cell transformation. Mol Cell Biol (1984) 6.40
Monensin interrupts the recycling of low density lipoprotein receptors in human fibroblasts. Cell (1981) 5.59
Requirement for c-ras proteins during viral oncogene transformation. Nature (1986) 5.24
The transforming proteins of Rous sarcoma virus, Harvey sarcoma virus and Abelson virus contain tightly bound lipid. Cell (1982) 4.66
Plasma cell immunoglobulin secretion: arrest is accompanied by alterations of the golgi complex. J Exp Med (1977) 4.59
The p21 ras C-terminus is required for transformation and membrane association. Nature (1984) 4.43
Localization of the src gene product of the Harvey strain of MSV to plasma membrane of transformed cells by electron microscopic immunocytochemistry. Cell (1980) 4.35
Intracellular transport of secretory and membrane proteins in hepatoma cells infected by vesicular stomatitis virus. Cell (1980) 4.15
Amino terminal myristylation of the protein kinase p60src, a retroviral transforming protein. Science (1985) 3.97
The purified product of the transforming gene of avian sarcoma virus phosphorylates tyrosine. J Biol Chem (1980) 3.95
Expression of the large T protein of polyoma virus promotes the establishment in culture of "normal" rodent fibroblast cell lines. Proc Natl Acad Sci U S A (1983) 3.65
Comparative studies of intracellular transport of secretory proteins. J Cell Biol (1978) 3.62
The complex of polyoma virus middle-T antigen and pp60c-src. EMBO J (1984) 3.57
Myristic acid, a rare fatty acid, is the lipid attached to the transforming protein of Rous sarcoma virus and its cellular homolog. J Virol (1985) 3.47
Vesicular stomatitis virus and sindbis virus glycoprotein transport to the cell surface is inhibited by ionophores. Virology (1980) 3.13
Monensin inhibits Semliki Forest virus penetration into culture cells. Proc Natl Acad Sci U S A (1982) 2.46
Altered sites of tyrosine phosphorylation in pp60c-src associated with polyomavirus middle tumor antigen. Mol Cell Biol (1986) 2.32
Loss of epidermal growth factor requirement and malignant transformation. Proc Natl Acad Sci U S A (1979) 1.65
Monensin blocks the transport of diphtheria toxin to the cell cytoplasm. J Cell Biol (1982) 1.58
Transformation of chicken embryo fibroblasts and tumor induction by the middle T antigen of polyomavirus carried in an avian retroviral vector. Mol Cell Biol (1986) 1.58
Differential subcellular localization of in vivo-phosphorylated and nonphosphorylated middle-sized tumor antigen of polyoma virus and its relationship to middle-sized tumor antigen phosphorylating activity in vitro. Proc Natl Acad Sci U S A (1982) 1.51
Inhibition of pinocytosis in rat embryo fibroblasts treated with monensin. J Cell Biol (1982) 1.48
Differential effect of monensin on enveloped viruses that form at distinct plasma membrane domains. J Cell Biol (1981) 1.44
A selective temperature-sensitive defect in viral RNA expression in cells infected with a ts transformation mutant of murine sarcoma virus. Cell (1981) 1.43
Role of the three polyoma virus early proteins in tumorigenesis. Mol Cell Biol (1983) 1.40
The growth requirements of SV40 virus transformed Balb/c-3T3 cells in serum-free monolayer culture. J Cell Physiol (1980) 1.10
Biochemical properties of p60v-src mutants that induce different cell transformation parameters. J Virol (1986) 1.03
Epidermal growth factor-nonresponsive 3T3 variants do not contain epidermal growth factor receptor-related antigens or mRNA. Proc Natl Acad Sci U S A (1986) 0.98
Low binding capacity and altered O-linked glycosylation of low density lipoprotein receptor in a monensin-resistant mutant of Chinese hamster ovary cells. J Biol Chem (1987) 0.98
Molecules involved in proliferation of normal and cancer cells: presidential address. Cancer Res (1987) 0.95
Anchorage-independent colony formation of SV40 transformed BALB/c-3T3 cells in serum-free medium: role of cell- and serum-derived factors. Cell (1983) 0.93
Binding and internalization of alpha 2-microglobulin by cultured fibroblasts. Effects of monovalent ionophores. Exp Cell Res (1982) 0.86
Characterization of the chimeric SV40 large T antigen which has a membrane attachment sequence of polyoma virus middle T antigen. Virology (1986) 0.83
Monensin-resistant mouse Balb/3T3 cell mutant with aberrant penetration of vesicular stomatitis virus. J Cell Biol (1985) 0.82
Chinese hamster ovary cell variants resistant to monensin, an ionophoric antibiotic. II. Growth requirement for insulin and altered insulin-receptor activity. J Cell Physiol (1984) 0.80
Chinese hamster ovary cell variants resistant to monensin, an ionophoric antibiotic. I. Isolation and altered endocytosis of ricin. J Cell Physiol (1984) 0.78
Mouse Balb/c3T3 cell mutant with low epidermal growth factor receptor activity: induction of stable anchorage-independent growth by transforming growth factor beta. J Cell Physiol (1987) 0.77
Mitogen-specific nonresponsive mutants and the initiation of cellular proliferation. Bioessays (1987) 0.77
Effect of 5-azacytidine on malignant transformation of a mutant derived from the mouse BALB/c 3T3 cell line resistant to transformation by chemical carcinogens. Cancer Res (1987) 0.77
Chinese hamster ovary cell mutant with defective down-regulation of low density lipoprotein receptors. J Biol Chem (1987) 0.77
Defective endocytosis of low-density lipoprotein in monensin-resistant mutants of the mouse Balb/3T3 cell line. J Cell Physiol (1985) 0.76
The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J (1996) 4.55
Characterization of Y73, an avian sarcoma virus: a unique transforming gene and its product, a phosphopolyprotein with protein kinase activity. Proc Natl Acad Sci U S A (1980) 3.58
Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol (1997) 3.02
A conditional lethal mutation in an Escherichia coli strain with a longer chemical lifetime of messenger RNA. J Mol Biol (1979) 2.87
Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha. Int J Cancer (2000) 2.64
Binding of adenosine 3':5'-cyclic phosphate to G factor of Escherichia coli, and its effects on GTPase, RNase V, and protein synthesis. Proc Natl Acad Sci U S A (1970) 2.49
Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin Cancer Res (1999) 1.93
Biological implications of macrophage infiltration in human tumor angiogenesis. Cancer Chemother Pharmacol (1999) 1.91
Gene affecting longevity of messenger RNA: a mutant of Escherichia coli with altered mRNA stability. Mol Gen Genet (1977) 1.90
A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res (1996) 1.90
A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis. Oncogene (1997) 1.88
Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J Biol Chem (1996) 1.81
Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res (1995) 1.76
Loss of dispensable endonuclease activity in relief of polarity by suA. Nat New Biol (1971) 1.76
Decreased expression of an ATP-binding cassette transporter, MRP2, in human livers with hepatitis C virus infection. J Hepatol (2001) 1.54
Differential subcellular localization of in vivo-phosphorylated and nonphosphorylated middle-sized tumor antigen of polyoma virus and its relationship to middle-sized tumor antigen phosphorylating activity in vitro. Proc Natl Acad Sci U S A (1982) 1.51
Significance of the expression of proliferation-associated nucleolar antigen p120 in human colorectal tumors. Hum Pathol (1997) 1.45
Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. Cancer Res (1995) 1.43
Cloning, sequence analysis, and expression of alteration of the mRNA stability gene (ams+) of Escherichia coli. J Bacteriol (1985) 1.43
Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol Cell Biol (1996) 1.42
Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen. Cancer Res (1999) 1.38
Enhanced coexpression of YB-1 and DNA topoisomerase II alpha genes in human colorectal carcinomas. Int J Cancer (1999) 1.37
G factor mutants of Escherichia coli: map location and properties. Biochem Biophys Res Commun (1971) 1.35
Genetic analysis of mutations affecting ribonuclease II in Escherichia coli. Mol Gen Genet (1977) 1.34
Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer. Clin Cancer Res (2001) 1.33
Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. Cancer Res (1996) 1.33
Metabolic fate of oxidized guanine ribonucleotides in mammalian cells. Biochemistry (1999) 1.30
Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene. J Biol Chem (1998) 1.25
The activity of soluble VCAM-1 in angiogenesis stimulated by IL-4 and IL-13. J Immunol (2000) 1.24
Ribonuclease V of escherichia coli. I. Dependence on ribosomes and translocation. Proc Natl Acad Sci U S A (1969) 1.23
Nuclear translocation of the Y-box binding protein by ultraviolet irradiation. FEBS Lett (1997) 1.22
Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression. Oncogene (2000) 1.21
Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome. Am J Hum Genet (1999) 1.21
A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells. Cancer Res (1997) 1.19
Chromosomal location of a gene for chemical longevity of messenger ribonculeic acid in a temperature-sensitive mutant of Escherichia coli. J Bacteriol (1980) 1.19
Mobility of the doped holes and the antiferromagnetic correlations in underdoped high- Tc cuprates. Phys Rev Lett (2001) 1.18
Mutations in the canilicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome. Hum Mol Genet (1998) 1.17
Suppression of retinal neovascularization by the NF-kappaB inhibitor pyrrolidine dithiocarbamate in mice. Invest Ophthalmol Vis Sci (1999) 1.17
Mutation affecting the thermolability of the 50S ribosomal subunit in Escherichia coli. J Bacteriol (1978) 1.16
Clinical significance of multi-drug resistance associated protein and P-glycoprotein in patients with bladder cancer. J Urol (1997) 1.16
Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog. Mol Pharmacol (1988) 1.15
Simian virus 40 gene A regulates the association between a highly phosphorylated protein and chromatin and ribosomes in simian virus 40-transformed cells. J Virol (1977) 1.15
Multipotent marrow stromal cell line is able to induce hematopoiesis in vivo. J Cell Physiol (1992) 1.13
Su-II-specific restriction of amber suppression by mutation to streptomycin resistance. J Mol Biol (1968) 1.13
Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias. Blood (1998) 1.12
Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma. Clin Cancer Res (1998) 1.12
Synthesis and structure--activity analysis of novel dihydropyridine derivatives to overcome multidrug resistance. Bioorg Med Chem Lett (2001) 1.12
Phosphorylation of E2F-1 by cyclin A-cdk2. Oncogene (1995) 1.12
Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells. Oncogene (2006) 1.11
The mechanism for the activation of latent TGF-beta during co-culture of endothelial cells and smooth muscle cells: cell-type specific targeting of latent TGF-beta to smooth muscle cells. J Cell Biol (1993) 1.10
Hepatocyte growth factor modulates migration and proliferation of human microvascular endothelial cells in culture. Biochem Biophys Res Commun (1991) 1.10
Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma. Hepatology (1998) 1.10
Two tumor antigens and their polypeptides in adenovirus type 12-infected and transformed cells. Proc Natl Acad Sci U S A (1980) 1.10
Y box-binding protein-1 binds preferentially to single-stranded nucleic acids and exhibits 3'-->5' exonuclease activity. Nucleic Acids Res (2001) 1.09
Peptic ulcer is prevalent among shift workers. Dig Dis Sci (1987) 1.09
Is nuclear expression of Y box-binding protein-1 a new prognostic factor in ovarian serous adenocarcinoma? Cancer (1999) 1.08
Enhanced expression of the human multidrug resistance protein 3 by bile salt in human enterocytes. A transcriptional control of a plausible bile acid transporter. J Biol Chem (2001) 1.08
The direct activation of human multidrug resistance gene (MDR1) by anticancer agents. Biochem Biophys Res Commun (1989) 1.07
Increased expression of T-plastin gene in cisplatin-resistant human cancer cells: identification by mRNA differential display. FEBS Lett (1996) 1.07
3',5'-cyclic adenosine monophosphate-requiring mutants of Escherichia coli. J Bacteriol (1972) 1.06
Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter. Mol Pharmacol (1999) 1.06
Specific binding of 8-oxoguanine-containing RNA to polynucleotide phosphorylase protein. Biochemistry (2001) 1.06
Structural basis for the regulation of UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase-3 gene expression in adenocarcinoma cells. Cancer Res (1999) 1.05
Cyclin-dependent kinase-2 (Cdk2) forms an inactive complex with cyclin D1 since Cdk2 associated with cyclin D1 is not phosphorylated by Cdk7-cyclin-H. Eur J Biochem (1996) 1.04
Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation. Cell Growth Differ (1993) 1.04
Endogenous basic fibroblast growth factor-dependent induction of collagenase and interleukin-6 in tumor necrosis factor-treated human microvascular endothelial cells. J Biol Chem (1991) 1.03
Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas. Clin Cancer Res (2000) 1.03
Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2). FEBS Lett (1999) 1.03
Increased phosphorylation of DNA topoisomerase II in etoposide-resistant mutants of human cancer KB cells. Cancer Res (1991) 1.02
Generation and elimination of 8-oxo-7,8-dihydro-2'-deoxyguanosine 5'-triphosphate, a mutagenic substrate for DNA synthesis, in human cells. Biochemistry (1995) 1.02
Increased expression of highly branched N-glycans at cell surface is correlated with the malignant phenotypes of mouse tumor cells. Cancer Res (1997) 1.01
In vitro translation of adenovirus type 12-specific mRNA complementary to the transforming gene. Virology (1980) 1.01
Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein. Eur J Pharmacol (2000) 1.00
Potentiation of 5-fluorouracil, chromomycin A3, and bleomycin by amphotericin B or polymyxin B in transformed fibroblastic cells. Antimicrob Agents Chemother (1973) 1.00
Co-expression of thymidine phosphorylase and heme oxygenase-1 in macrophages in human malignant vertical growth melanomas. Jpn J Cancer Res (2000) 1.00
Localization of elastin in the normal and glaucomatous human trabecular meshwork. Invest Ophthalmol Vis Sci (1994) 1.00
Mutations to spectinomycin resistance which alleviate the restriction of an amber suppressor by streptomycin resistance. J Bacteriol (1969) 1.00
Potentiation of bleomycin by an antifungal polyene, pentamycin, in transformed animal cells. Cancer Res (1974) 1.00
A new monkey lymphotropic papovavirus: characterization of the virus and evidence of a related virus in humans. Prog Clin Biol Res (1983) 1.00
The utility of endoscopic ultrasonography and endoscopy in the endoscopic mucosal resection of early gastric cancer. Gut (1999) 0.99
Neoplastic transformation of rat 3Y1 cells by a transcriptionally activated human c-myc gene and stabilization of p53 cellular tumor antigen in the transformed cells. Mol Cell Biol (1986) 0.98
Low binding capacity and altered O-linked glycosylation of low density lipoprotein receptor in a monensin-resistant mutant of Chinese hamster ovary cells. J Biol Chem (1987) 0.98
Isolation and characterization of amphotericin B-resistant cell lines in Chinese hamster cells. Cell (1978) 0.98
MDR1 gene overexpression and altered degree of methylation at the promoter region in bladder cancer during chemotherapeutic treatment. Clin Cancer Res (2000) 0.98
Possible involvement of multidrug-resistance-associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells. Int J Cancer (1994) 0.97
Comparative study on E6 and E7 genes of some cutaneous and genital papillomaviruses of human origin for their ability to transform 3Y1 cells. Virology (1993) 0.97
Temperature-sensitive mutation in regulation of ribonucleic acid synthesis in Escherichia coli. J Bacteriol (1972) 0.97
Multicopy plasmid with a structure related to the polyoma virus genome. Proc Natl Acad Sci U S A (1987) 0.96
Characterization of N-type and dually permissive cells segregated from mouse fibroblasts whose Fv-1 phenotype could be modified by another independently segregating gene(s). J Virol (1982) 0.96
Chimeric YACs were generated at unreduced rates in conditions that suppress coligation. Nucleic Acids Res (1994) 0.96
Differential effects of brefeldin A on sialylation of N- and O-linked oligosaccharides in low density lipoprotein receptor and epidermal growth factor receptor. J Biol Chem (1990) 0.96
Antibodies against a nonapeptide of polyomavirus middle T antigen: cross-reaction with a cellular protein(s). J Virol (1983) 0.95
Induction of low density lipoprotein receptor and a transcription factor SP-1 by tumor necrosis factor in human microvascular endothelial cells. J Biol Chem (1992) 0.95
The human multidrug resistance protein 2 gene: functional characterization of the 5'-flanking region and expression in hepatic cells. Hepatology (1999) 0.95
High expression of the Cap43 gene in infiltrating macrophages of human renal cell carcinomas. Clin Cancer Res (2001) 0.95
Effect of bisbenzylisoquinoline (biscoclaurine) alkaloids on multidrug resistance in KB human cancer cells. Cancer Res (1987) 0.95
Class IC antiarrhythmic drugs, flecainide and pilsicainide, produce ST segment elevation simulating inferior myocardial ischemia. J Cardiovasc Electrophysiol (1998) 0.94
The stimulatory effect of PDGF on vascular smooth muscle cell migration is mediated by the induction of endogenous basic FGF. Biochem Biophys Res Commun (1991) 0.94
Induction of macrophage inflammatory protein-1alpha and vascular endothelial growth factor during inflammatory neovascularization in the mouse cornea. Angiogenesis (1999) 0.94